Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionATP-dependent activity

DDX19B DDX19A DNAH3 MYH8 DDX59 MYO7B ATP10B ZRANB3 BPTF DNAH12 MCM9 ATP2C2 DNAH5 HSPA4 HSPA5 ACSL5 HSP90AA4P

2.64e-0661414617GO:0140657
GeneOntologyMolecularFunctionpyrophosphatase activity

DDX19B DDX19A DNAH3 MYH8 DDX59 ATP10B RGS4 GSPT1 DNAH12 GSPT2 ASMTL MCM9 ATP2C2 ENTPD6 GNAO1 DNAH5 HSPA5 HSP90AA4P

4.21e-0583914618GO:0016462
GeneOntologyMolecularFunctionhydrolase activity, acting on acid anhydrides

DDX19B DDX19A DNAH3 MYH8 DDX59 ATP10B RGS4 GSPT1 DNAH12 GSPT2 ASMTL MCM9 ATP2C2 ENTPD6 GNAO1 DNAH5 HSPA5 HSP90AA4P

4.28e-0584014618GO:0016817
GeneOntologyMolecularFunctionhydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides

DDX19B DDX19A DNAH3 MYH8 DDX59 ATP10B RGS4 GSPT1 DNAH12 GSPT2 ASMTL MCM9 ATP2C2 ENTPD6 GNAO1 DNAH5 HSPA5 HSP90AA4P

4.28e-0584014618GO:0016818
GeneOntologyMolecularFunctiondynein light intermediate chain binding

DNAH3 RILPL2 DNAH12 DNAH5

4.90e-05281464GO:0051959
GeneOntologyMolecularFunctionribonucleoside triphosphate phosphatase activity

DDX19B DDX19A DNAH3 MYH8 DDX59 ATP10B RGS4 GSPT1 DNAH12 GSPT2 MCM9 ATP2C2 ENTPD6 GNAO1 DNAH5 HSPA5 HSP90AA4P

5.32e-0577514617GO:0017111
GeneOntologyMolecularFunctionATP hydrolysis activity

DDX19B DDX19A DNAH3 MYH8 DDX59 ATP10B DNAH12 MCM9 ATP2C2 DNAH5 HSPA5 HSP90AA4P

9.91e-0544114612GO:0016887
GeneOntologyMolecularFunctionprostaglandin transmembrane transporter activity

SLCO1B3 SLCO1B1 SLCO1B7

1.31e-04141463GO:0015132
GeneOntologyMolecularFunctionicosanoid transmembrane transporter activity

SLCO1B3 SLCO1B1 SLCO1B7

1.63e-04151463GO:0071714
GeneOntologyMolecularFunctionoligopeptide transmembrane transporter activity

SLCO1B3 SLCO1B1 SLCO1B7

2.00e-04161463GO:0035673
GeneOntologyMolecularFunctionsodium-independent organic anion transmembrane transporter activity

SLCO1B3 SLCO1B1 SLCO1B7

2.88e-04181463GO:0015347
GeneOntologyMolecularFunctionminus-end-directed microtubule motor activity

DNAH3 DNAH12 DNAH5

2.88e-04181463GO:0008569
GeneOntologyMolecularFunctiontranslation termination factor activity

GSPT1 GSPT2

1.09e-0371462GO:0008079
GeneOntologyMolecularFunctiontranslation release factor activity

GSPT1 GSPT2

1.09e-0371462GO:0003747
GeneOntologyBiologicalProcessRNA transport

DDX19B TPR DDX19A CKAP5 UPF3B UPF3A SNUPN NUP205

2.64e-051751408GO:0050658
GeneOntologyBiologicalProcessnucleic acid transport

DDX19B TPR DDX19A CKAP5 UPF3B UPF3A SNUPN NUP205

2.64e-051751408GO:0050657
GeneOntologyBiologicalProcessestablishment of RNA localization

DDX19B TPR DDX19A CKAP5 UPF3B UPF3A SNUPN NUP205

2.98e-051781408GO:0051236
GeneOntologyBiologicalProcesspigment catabolic process

SLCO1B3 HMOX2 SLCO1B1

4.85e-05111403GO:0046149
GeneOntologyBiologicalProcessheme catabolic process

SLCO1B3 HMOX2 SLCO1B1

4.85e-05111403GO:0042167
GeneOntologyBiologicalProcessporphyrin-containing compound catabolic process

SLCO1B3 HMOX2 SLCO1B1

8.33e-05131403GO:0006787
GeneOntologyBiologicalProcesstetrapyrrole catabolic process

SLCO1B3 HMOX2 SLCO1B1

1.05e-04141403GO:0033015
GeneOntologyBiologicalProcessRNA localization

DDX19B TPR DDX19A CKAP5 UPF3B UPF3A SNUPN NUP205

1.20e-042171408GO:0006403
GeneOntologyBiologicalProcesssodium-independent organic anion transport

SLCO1B3 SLCO1B1 SLCO1B7

1.31e-04151403GO:0043252
MousePhenoembryonic lethality prior to organogenesis

TRAPPC11 NCAPD3 DDX59 WASHC4 KMT2B TOPBP1 CKAP5 UPF3A TRRAP PRPF40A RGS4 YARS1 GSPT1 NUP205 BPTF IARS2 NF2 PI4KA UGDH FLCN EXOC1 LTV1 DGCR8 TMEM41B HSPA5 TBP

7.44e-06120411926MP:0013292
MousePhenoanosmia

CEP290 SCN9A CNGA2

2.05e-0571193MP:0004512
MousePhenoembryonic lethality prior to tooth bud stage

EHBP1 TRAPPC11 NCAPD3 DDX59 WASHC4 KMT2B TOPBP1 CKAP5 UPF3A TRRAP PRPF40A RGS4 YARS1 GSPT1 NUP205 BPTF IARS2 NF2 PI4KA UGDH FLCN EXOC1 LTV1 DGCR8 TMEM41B HSPA5 TBP

2.99e-05138311927MP:0013293
DomainSmg4_UPF3

UPF3B UPF3A

6.15e-0521472PF03467
DomainNonsense_mediated_decay_UPF3

UPF3B UPF3A

6.15e-0521472IPR005120
DomainPHD

KMT2B ZMYND8 UBR7 BPTF SP140L PHF3

7.29e-05891476SM00249
DomainZnf_PHD

KMT2B ZMYND8 UBR7 BPTF SP140L PHF3

8.25e-05911476IPR001965
DomainOA_transporter

SLCO1B3 SLCO1B1 SLCO1B7

9.98e-05121473IPR004156
DomainOATP

SLCO1B3 SLCO1B1 SLCO1B7

9.98e-05121473PF03137
DomainZF_PHD_2

KMT2B ZMYND8 UBR7 BPTF SP140L PHF3

1.05e-04951476PS50016
DomainZF_PHD_1

KMT2B ZMYND8 UBR7 BPTF SP140L PHF3

1.11e-04961476PS01359
DomainDynein_heavy_chain_D4_dom

DNAH3 DNAH12 DNAH5

1.63e-04141473IPR024317
DomainDynein_heavy_dom-2

DNAH3 DNAH12 DNAH5

1.63e-04141473IPR013602
DomainDHC_N2

DNAH3 DNAH12 DNAH5

1.63e-04141473PF08393
DomainATPase_dyneun-rel_AAA

DNAH3 DNAH12 DNAH5

1.63e-04141473IPR011704
DomainAAA_8

DNAH3 DNAH12 DNAH5

1.63e-04141473PF12780
DomainAAA_5

DNAH3 DNAH12 DNAH5

1.63e-04141473PF07728
DomainZnf_FYVE_PHD

SPIRE2 KMT2B ZMYND8 UBR7 BPTF SP140L PHF3

1.65e-041471477IPR011011
DomainDHC_fam

DNAH3 DNAH12 DNAH5

2.03e-04151473IPR026983
DomainDynein_heavy

DNAH3 DNAH12 DNAH5

2.03e-04151473PF03028
DomainDynein_heavy_dom

DNAH3 DNAH12 DNAH5

2.03e-04151473IPR004273
DomainPHD

KMT2B ZMYND8 BPTF SP140L PHF3

3.13e-04751475PF00628
DomainHIN_200

IFI16 AIM2

3.65e-0441472PS50834
DomainHIN

IFI16 AIM2

3.65e-0441472PF02760
DomainHIN200/IF120x

IFI16 AIM2

3.65e-0441472IPR004021
DomainZnf_PHD-finger

KMT2B ZMYND8 BPTF SP140L PHF3

3.98e-04791475IPR019787
DomainNA-bd_OB-fold

IFI16 YARS1 DARS2 MCM9 AIM2

5.00e-04831475IPR012340
DomainHSR

SP100 SP140L

6.06e-0451472PS51414
DomainHSR

SP100 SP140L

6.06e-0451472PF03172
DomainHSR_dom

SP100 SP140L

6.06e-0451472IPR004865
DomainDAPIN

IFI16 NLRP9 AIM2

6.59e-04221473PS50824
DomainPYRIN

IFI16 NLRP9 AIM2

6.59e-04221473SM01289
DomainPYRIN

IFI16 NLRP9 AIM2

6.59e-04221473PF02758
DomainDAPIN

IFI16 NLRP9 AIM2

6.59e-04221473IPR004020
Domain-

DDX19B DDX19A DNAH3 DDX59 MYO7B ZRANB3 GSPT1 NLRP9 DNAH12 GSPT2 N4BP2 MCM9 GNAO1 DNAH5 HYDIN

8.11e-04746147153.40.50.300
DomainP-loop_NTPase

DDX19B DDX19A DNAH3 MYH8 DDX59 MYO7B ZRANB3 GSPT1 NLRP9 DNAH12 GSPT2 N4BP2 MCM9 GNAO1 DNAH5 HYDIN

1.06e-0384814716IPR027417
DomainARM-like

NCAPD3 CKAP5 ARFGEF1 HEATR1 MEI1 TRRAP PACRGL TBP

1.36e-032701478IPR011989
DomainARM-type_fold

NCAPD3 CKAP5 ARFGEF1 HEATR1 MEI1 TRRAP FMNL3 PACRGL PI4KA

1.48e-033391479IPR016024
DomainSAND_dom

SP100 SP140L

1.67e-0381472IPR000770
DomainTransl_elong_EFTu/EF1A_C

GSPT1 GSPT2

1.67e-0381472IPR004160
DomainSAND

SP100 SP140L

1.67e-0381472PF01342
DomainGTP_EFTU_D3

GSPT1 GSPT2

1.67e-0381472PF03143
DomainSAND

SP100 SP140L

1.67e-0381472PS50864
DomainSAND

SP100 SP140L

1.67e-0381472SM00258
DomainZinc_finger_PHD-type_CS

ZMYND8 BPTF SP140L PHF3

1.72e-03651474IPR019786
Domain-

NCAPD3 CKAP5 ARFGEF1 HEATR1 TRRAP PACRGL TBP

1.91e-0322214771.25.10.10
DomainG_TR_CS

GSPT1 GSPT2

2.14e-0391472IPR031157
DomainTransl_elong_EF1A/Init_IF2_C

GSPT1 GSPT2

2.66e-03101472IPR009001
DomainKazal_2

SLCO1B3 SLCO1B1 SLCO1B7

2.82e-03361473PF07648
DomainQ_MOTIF

DDX19B DDX19A DDX59

3.05e-03371473PS51195
DomainRNA_helicase_DEAD_Q_motif

DDX19B DDX19A DDX59

3.05e-03371473IPR014014
DomainSecretoglobin

TOPBP1 SCGB1D1

3.23e-03111472IPR016126
DomainBromodomain

ZMYND8 BPTF SP140L

3.29e-03381473PF00439
Domain-

SP100 SP140L

3.86e-031214723.10.390.10
Domain-

HSPA4 HSPA5

3.86e-031214722.60.34.10
DomainHSP70_peptide-bd

HSPA4 HSPA5

3.86e-03121472IPR029047
DomainSAND_dom-like

SP100 SP140L

3.86e-03121472IPR010919
DomainBROMODOMAIN_2

ZMYND8 BPTF SP140L

4.09e-03411473PS50014
DomainBromodomain

ZMYND8 BPTF SP140L

4.38e-03421473IPR001487
DomainBROMO

ZMYND8 BPTF SP140L

4.38e-03421473SM00297
Domain-

ZMYND8 BPTF SP140L

4.38e-034214731.20.920.10
DomainG_TR_1

GSPT1 GSPT2

4.53e-03131472PS00301
Domain-

HSPA4 HSPA5

4.53e-031314721.20.1270.10
DomainHeat_shock_70_CS

HSPA4 HSPA5

4.53e-03131472IPR018181
DomainHSP70_C

HSPA4 HSPA5

4.53e-03131472IPR029048
DomainDynein_HC_stalk

DNAH3 DNAH5

5.26e-03141472IPR024743
DomainMT

DNAH3 DNAH5

5.26e-03141472PF12777
DomainEF-hand_like

PLCZ1 PLCG2

6.04e-03151472PF09279
DomainPI-PLC-Y

PLCZ1 PLCG2

6.04e-03151472PF00387
DomainPLCYc

PLCZ1 PLCG2

6.04e-03151472SM00149
DomainPLipase_C_Pinositol-sp_Y

PLCZ1 PLCG2

6.04e-03151472IPR001711
DomainPIPLC_Y_DOMAIN

PLCZ1 PLCG2

6.04e-03151472PS50008
DomainPI-PLC_fam

PLCZ1 PLCG2

6.04e-03151472IPR001192
DomainPLC_EF-hand-like

PLCZ1 PLCG2

6.04e-03151472IPR015359
DomainHEAT

NCAPD3 CKAP5 HEATR1

6.38e-03481473PF02985
Domain-

TRRAP PI4KA

6.87e-031614721.10.1070.11
DomainPI3Kc

TRRAP PI4KA

6.87e-03161472SM00146
DomainHSP70

HSPA4 HSPA5

6.87e-03161472PF00012
DomainKAZAL_2

SLCO1B3 SLCO1B1 SLCO1B7

7.15e-03501473PS51465
DomainKazal_dom

SLCO1B3 SLCO1B1 SLCO1B7

7.55e-03511473IPR002350
DomainHSP70_2

HSPA4 HSPA5

7.74e-03171472PS00329
DomainHSP70_1

HSPA4 HSPA5

7.74e-03171472PS00297
DomainHSP70_3

HSPA4 HSPA5

7.74e-03171472PS01036
PathwayREACTOME_HEME_DEGRADATION

SLCO1B3 HMOX2 SLCO1B1 SLCO1B7

1.44e-05201084MM14721
PathwayREACTOME_TRANSPORT_OF_ORGANIC_ANIONS

SLCO1B3 SLCO1B1 SLCO1B7

9.15e-05121083MM15476
PathwayREACTOME_METABOLISM_OF_PORPHYRINS

SLCO1B3 HMOX2 SLCO1B1 SLCO1B7

9.93e-05321084MM14719
PathwayREACTOME_HEME_DEGRADATION

SLCO1B3 HMOX2 SLCO1B1

1.86e-04151083M27060
PathwayREACTOME_ATORVASTATIN_ADME

SLCO1B3 SLCO1B1 SLCO1B7

1.86e-04151083MM15697
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

TPR DDX19A RPL27A NCAPD3 HK1 ACAD9 POLR2A KTN1 CKAP5 UPF3B HEATR1 LYAR PRPF40A YARS1 DARS2 ESF1 GSPT1 NUP205 IARS2 PI4KA CSTB LTV1 PRMT3 DNAH5 HSPA4 CLUH HSPA5

9.12e-1114251502730948266
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

TPR DDX19A RPL27A HK1 WASHC4 POLR2A KTN1 CKAP5 HEATR1 LYAR IFI16 TRRAP ESF1 GSPT1 NUP205 LLGL1 PI4KA ASPH UGDH EXOC1 LTV1 PRMT3 PLCG2 HSPA4 HSPA5

8.32e-1013531502529467282
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

RPL27A NCAPD3 KTN1 TOPBP1 CKAP5 UPF3B HEATR1 LYAR TRRAP ESF1 NUP205 BPTF PHF3 MCM9 ASPH LTV1 DGCR8

3.51e-087591501735915203
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

TPR NCAPD3 IFT81 POLR2A KTN1 ZMYND8 CKAP5 HEATR1 TRRAP YARS1 DARS2 NUP205 TRAPPC13 BPTF IARS2 ASMTL PI4KA TBP

3.58e-088571501825609649
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

TPR NCAPD3 KMT2B POLR2A ZMYND8 CKAP5 GPATCH8 IFI16 TRRAP PRPF40A ESF1 STRIP1 BPTF PHF3 ASPH AFF1 CLUH

4.65e-087741501715302935
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

RPL27A SP100 MYH8 HK1 IFT81 KTN1 EML6 ATP10B HEATR1 HMOX2 NEB RNF17 PRX ESF1 GSPT1 NUP205 BPTF TNRC18 GSPT2 N4BP2 SCN9A GNAO1 HSPA5

6.37e-0814421502335575683
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

DDX19B DDX19A RPL27A SP100 HK1 WASHC4 POLR2A KTN1 UBR7 YARS1 GSPT1 NUP205 GSPT2 ASMTL UGDH CSTB STK39 LTV1 PRMT3 HSPA4 CLUH HSPA5 HSP90AA4P

7.48e-0814551502322863883
Pubmed

Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR.

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150318296417
Pubmed

Role of the murine organic anion-transporting polypeptide 1b2 (Oatp1b2) in drug disposition and hepatotoxicity.

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150318492796
Pubmed

Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx.

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150328389619
Pubmed

Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics.

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150323986199
Pubmed

Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice.

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150320949553
Pubmed

Synergistic interaction between genetics and disease on pravastatin disposition.

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150324613363
Pubmed

Full-length cDNA cloning and genomic organization of the mouse liver-specific organic anion transporter-1 (lst-1).

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150310833452
Pubmed

Interaction Between Sex and Organic Anion-Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib-N-Oxide and Regorafenib-Glucuronide in Mice.

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150330955241
Pubmed

Influence of drug formulation on OATP1B-mediated transport of paclitaxel.

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150324755470
Pubmed

OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity.

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150329337310
Pubmed

Expression of Oatp2 in the Brain and Liver of Alzheimer Disease Mouse Model.

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150331967785
Pubmed

Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin.

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150318413659
Pubmed

Identification, expression, and functional characterization of full-length and splice variants of murine organic anion transporting polypeptide 1b2.

SLCO1B3 SLCO1B1 SLCO1B7

7.86e-083150319400585
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

CYLD HK1 PPFIBP1 ACAD9 IFT81 KTN1 HEATR1 HMOX2 PRPF40A DARS2 ESF1 IARS2 LLGL1 TIAM1 NF2 N4BP2 PI4KA ASPH CCDC138 LTV1 HSPA4 CLUH HSPA5

1.10e-0714871502333957083
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

RPL27A NCAPD3 SP100 WASHC4 KTN1 CKAP5 HEATR1 HMOX2 GPATCH8 IFI16 PRPF40A STRIP1 NUP205 SP140L PHF3 ASPH TMEM41B CLUH HSPA5 ACSL5

2.63e-0712031502029180619
Pubmed

Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain.

SLCO1B3 SLCO1B1 SLCO1B7

3.14e-074150322294745
Pubmed

Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs.

SLCO1B3 SLCO1B1 SLCO1B7

3.14e-074150320644253
Pubmed

Protection against phalloidin-induced liver injury by oleanolic acid involves Nrf2 activation and suppression of Oatp1b2.

SLCO1B3 SLCO1B1 SLCO1B7

3.14e-074150325280775
Pubmed

Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance.

SLCO1B3 SLCO1B1 SLCO1B7

3.14e-074150327777271
Pubmed

Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay.

UPF3B UPF3A GSPT1 GSPT2

3.22e-0714150416452507
Pubmed

KAP1 facilitates reinstatement of heterochromatin after DNA replication.

DDX19B TRAPPC11 DDX19A NCAPD3 HK1 WASHC4 POLR2A ZMYND8 HEATR1 TRRAP DARS2 NUP205 IARS2 PRMT3 DNAH5

4.42e-077041501529955894
Pubmed

Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.

TPR RPL27A NCAPD3 KTN1 ZMYND8 CKAP5 LYAR PRPF40A YARS1 AMZ2 IARS2 ASPH UGDH EXOC1 HSPA4 HSPA5

4.80e-078091501632129710
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

TPR TCAF2 PPFIBP1 KTN1 YARS1 DARS2 BPTF GSPT2 STK39 EXOC1 HSPA4

5.19e-073601501133111431
Pubmed

OATP1A/1B transporters affect irinotecan and SN-38 pharmacokinetics and carboxylesterase expression in knockout and humanized transgenic mice.

SLCO1B3 SLCO1B1 SLCO1B7

7.81e-075150324194565
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

RPL27A NCAPD3 KMT2B POLR2A KTN1 CEP290 ZMYND8 TOPBP1 CKAP5 HEATR1 GPATCH8 LYAR IFI16 TRRAP PRPF40A BPTF PHF3 ASPH TMEM41B HSPA5

8.20e-0712941502030804502
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

TPR HK1 POLR2A CKAP5 HEATR1 TRRAP PRPF40A ESF1 NUP205 BPTF IARS2 PHF3 HSPA4 CLUH

1.01e-066531501422586326
Pubmed

TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.

HK1 KTN1 CKAP5 BPTF IARS2 HSPA4 HSPA5 TBP

1.19e-06179150836261009
Pubmed

Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.

SLCO1B3 SLCO1B1 SLCO1B7

1.56e-066150322232210
Pubmed

Analysis of DNA methylation and histone modification profiles of liver-specific transporters.

SLCO1B3 SLCO1B1 SLCO1B7

1.56e-066150319047482
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

ACAD9 IFT81 POLR2A KTN1 ZMYND8 MEI1 NEB TRRAP DNAH12 SCN9A RBM46 HYDIN

1.85e-064971501236774506
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

MYH8 WASHC4 PPFIBP1 UPF3B GPATCH8 TRRAP PRX DARS2 ESF1 CCDC138 FLCN AFF1 MMP1 HSPA4 HSPA5 ATG16L2

2.21e-069101501636736316
Pubmed

Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.

DNAH3 DNAH12 DNAH5

2.72e-06715039256245
Pubmed

Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.

TPR RPL27A DNAH3 SP100 HK1 TOPBP1 CKAP5 UPF3B NACAD PRPF40A CSTB LTV1 HSPA4 HSPA5 HSP90AA4P

4.29e-068471501535235311
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

CYLD DDX59 IFT81 POLR2A CEP290 TOPBP1 CKAP5 UPF3B UBR7 PI4KA CCDC138 EXOC1 GNAO1

4.90e-066451501325281560
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

TPR KMT2B POLR2A KTN1 HEATR1 TRRAP PRPF40A ESF1 BPTF NF2 PHF3 HSPA5

5.10e-065491501238280479
Pubmed

A High-Density Human Mitochondrial Proximity Interaction Network.

EHBP1 DDX19B DDX19A RPL27A HK1 ACAD9 KTN1 LRRC49 UPF3B HEATR1 HMOX2 YARS1 DARS2 ESF1 STRIP1 IARS2 PI4KA CCDC138 MIGA1 CLUH

7.27e-0614961502032877691
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

NCAPD3 KMT2B PPFIBP1 ACAD9 POLR2A KTN1 ZMYND8 TOPBP1 CKAP5 HEATR1 GPATCH8 LYAR TRRAP ESF1 STRIP1 PHF3 PI4KA ASPH DGCR8 TBP

7.35e-0614971502031527615
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

CYLD RPL27A HK1 PPFIBP1 ARFGEF1 BTBD3 ESF1 STRIP1 IARS2 NF2 PI4KA UGDH DGCR8 RPGR

7.49e-067771501435844135
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

DDX19B TPR RPL27A POLR2A KTN1 UPF3B UPF3A PRPF40A ESF1 GSPT1 TNRC18 GSPT2 NF2 PHF3 UGDH AFF1 HSPA4 HSPA5

7.77e-0612471501827684187
Pubmed

Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers.

SLCO1B3 SLCO1B1 SLCO1B7

9.23e-0610150318703564
Pubmed

FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands.

KMT2B PRPF40A FMNL3

9.23e-061015039171351
Pubmed

A Single Adaptable Cochaperone-Scaffold Complex Delivers Nascent Iron-Sulfur Clusters to Mammalian Respiratory Chain Complexes I-III.

CYLD DDX19A NCAPD3 ACAD9 HMOX2 DARS2 IARS2 LLGL1 ASPH MIGA1 STK39 PRMT3 CLUH

9.45e-066861501328380382
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

CYLD RPL27A ZNF234 WASHC4 PPFIBP1 IFT81 CEP290 ZMYND8 CKAP5 NCKAP5 HMOX2 YARS1 TIAM1 NF2 MIGA1 EXOC1 DGCR8 HSPA5

1.16e-0512851501835914814
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

TPR RPL27A DDX59 PPFIBP1 POLR2A KTN1 CKAP5 UPF3B LYAR YARS1 DARS2 GSPT1 GSPT2 ASPH CSTB LTV1 HSPA4 CLUH HSPA5

1.18e-0514151501928515276
Pubmed

Defining the membrane proteome of NK cells.

DDX19B DDX19A RPL27A NCAPD3 KTN1 CEP290 CKAP5 HEATR1 HMOX2 IFI16 PRPF40A NUP205 NF2 PI4KA EXOC1 HSPA5 ACSL5

1.27e-0511681501719946888
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

EHBP1 TPR RPL27A POLR2A KTN1 ZMYND8 CKAP5 UPF3B HEATR1 PRPF40A ESF1 IARS2 CSTB LTV1 HSPA4

1.37e-059341501533916271
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

TPR NCAPD3 POLR2A ZMYND8 CKAP5 GPATCH8 BPTF PHF3 HSPA5

1.51e-05332150932786267
Pubmed

Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.

SP100 POLR2A CKAP5 HEATR1 LYAR IFI16 PRPF40A ESF1 NUP205

1.51e-05332150925693804
Pubmed

Tagging genes with cassette-exchange sites.

ZMYND8 GPATCH8 RNF17 PRPF40A BPTF FLCN EXOC1 DGCR8 RPGR

1.62e-05335150915741177
Pubmed

The CTRB1-CTRB2 risk allele for chronic pancreatitis discovered in European populations does not contribute to disease risk variation in the Chinese population due to near allele fixation.

CTRB2 CTRB1

1.85e-052150228951524
Pubmed

The bacterium, nontypeable Haemophilus influenzae, enhances host antiviral response by inducing Toll-like receptor 7 expression: evidence for negative regulation of host anti-viral response by CYLD.

CYLD TLR7

1.85e-052150217608805
Pubmed

Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.

CTRB2 CTRB1

1.85e-052150228754779
Pubmed

Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease.

IFI16 AIM2

1.85e-052150226313692
Pubmed

Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation.

GSPT1 GSPT2

1.85e-052150215987998
Pubmed

Modulation of transporter activity of OATP1B1 and OATP1B3 by the major active components of Radix Ophiopogonis.

SLCO1B3 SLCO1B1

1.85e-052150229944058
Pubmed

SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome.

SLCO1B3 SLCO1B1

1.85e-052150236964102
Pubmed

Genetic variations in Toll-like receptors 4 or 7 were not linked to post-bronchiolitis lung function in adolescence.

TLR7 TLR4

1.85e-052150233053215
Pubmed

Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide.

SLCO1B3 SLCO1B1

1.85e-052150223340295
Pubmed

TLR4 and TLR7 genetic polymorphism in patients with HIV/HCV-coinfection: prevalence and gender-related features.

TLR7 TLR4

1.85e-052150230684342
Pubmed

Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition.

SLCO1B3 SLCO1B1

1.85e-052150229777022
Pubmed

Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis.

SLCO1B3 SLCO1B1

1.85e-052150226191226
Pubmed

Utility of Oatp1a/1b-knockout and OATP1B1/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein.

SLCO1B3 SLCO1B1

1.85e-052150224194513
Pubmed

Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA.

CTRB2 CTRB1

1.85e-05215022917002
Pubmed

Genomic cloning and partial characterization of human chymotrypsinogen gene.

CTRB2 CTRB1

1.85e-05215028186414
Pubmed

Differential Activation of NLRP3, AIM2, and IFI16 Inflammasomes in Humans with Acute and Chronic Hepatitis B.

IFI16 AIM2

1.85e-052150230222506
Pubmed

Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins.

SLCO1B3 SLCO1B1

1.85e-052150224855184
Pubmed

Spatial expression of the nonsense-mediated mRNA decay factors UPF3A and UPF3B among mouse tissues.

UPF3B UPF3A

1.85e-052150237961809
Pubmed

Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.

SLCO1B3 SLCO1B1

1.85e-052150226474710
Pubmed

Effects of anthocyans on the expression of organic anion transporting polypeptides (SLCOs/OATPs) in primary human hepatocytes.

SLCO1B3 SLCO1B1

1.85e-052150225578040
Pubmed

RNA polymerase II and TAFs undergo a slow isomerization after the polymerase is recruited to promoter-bound TFIID.

POLR2A TBP

1.85e-052150220083121
Pubmed

Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.

SLCO1B3 SLCO1B1

1.85e-052150224989890
Pubmed

PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.

IFI16 AIM2

1.85e-052150230980272
Pubmed

Filament assembly underpins the double-stranded DNA specificity of AIM2-like receptors.

IFI16 AIM2

1.85e-052150236864667
Pubmed

The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps.

IFI16 AIM2

1.85e-052150235608258
Pubmed

Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation.

UPF3B UPF3A

1.85e-052150217704778
Pubmed

Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport.

SLCO1B3 SLCO1B1

1.85e-052150221719246
Pubmed

Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians.

SLCO1B3 SLCO1B1

1.85e-052150220877131
Pubmed

Mammalian UPF3A and UPF3B can activate nonsense-mediated mRNA decay independently of their exon junction complex binding.

UPF3B UPF3A

1.85e-052150235451102
Pubmed

Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3.

SLCO1B3 SLCO1B1

1.85e-052150216534140
Pubmed

Human UPF3A and UPF3B enable fault-tolerant activation of nonsense-mediated mRNA decay.

UPF3B UPF3A

1.85e-052150235451084
Pubmed

Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.

SLCO1B3 SLCO1B1

1.85e-052150218321482
Pubmed

Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.

SLCO1B3 SLCO1B1

1.85e-052150218314419
Pubmed

OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation.

SLCO1B3 SLCO1B1

1.85e-052150221691816
Pubmed

The structure of an FF domain from human HYPA/FBP11.

POLR2A PRPF40A

1.85e-052150212381297
Pubmed

Titanium dioxide nanoparticles-mediated in vitro cytotoxicity does not induce Hsp70 and Grp78 expression in human bronchial epithelial A549 cells.

HSPA4 HSPA5

1.85e-052150222528773
Pubmed

The EHV-1 UL4 protein that tempers viral gene expression interacts with cellular transcription factors.

POLR2A TBP

1.85e-052150224418534
Pubmed

Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice.

CTRB2 CTRB1

1.85e-052150230076839
Pubmed

Linking organic anion transporting polypeptide 1B1 and 1B3 (OATP1B1 and OATP1B3) interaction profiles to hepatotoxicity - The hyperbilirubinemia use case.

SLCO1B3 SLCO1B1

1.85e-052150228063966
Pubmed

Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.

SLCO1B3 SLCO1B1

1.85e-052150222240838
Pubmed

Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis.

CTRB2 CTRB1

1.85e-052150233036922
Pubmed

Common Polymorphisms in IFI16 and AIM2 Genes Are Associated With Periodontal Disease.

IFI16 AIM2

1.85e-052150228387608
Pubmed

Identification of a potential tumor differentiation factor receptor candidate in prostate cancer cells.

HSPA4 HSPA5

1.85e-052150222613557
Pubmed

Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport.

SLCO1B3 SLCO1B1

1.85e-052150217412826
InteractionDCTN2 interactions

CYLD EHBP1 TPR POLR2A CKAP5 ARFGEF1 UPF3B IFI16 IARS2 N4BP2 CCDC138 RPGR GNAO1

2.01e-0635614613int:DCTN2
InteractionPRAP1 interactions

TRRAP ASPH LACRT HSPA5

7.47e-06181464int:PRAP1
InteractionHECTD1 interactions

RPL27A NCAPD3 KTN1 TOPBP1 CKAP5 UPF3B HEATR1 LYAR TRRAP PRPF40A ESF1 NUP205 BPTF NF2 PHF3 MCM9 ASPH EXOC1 LTV1 DGCR8 HSPA4

8.59e-0698414621int:HECTD1
GeneFamilyPHD finger proteins

SP100 KMT2B ZMYND8 BPTF SP140L PHF3

6.92e-069093688
GeneFamilyNucleoporins

DDX19B TPR DDX19A NUP205

2.11e-05329341051
GeneFamilyDyneins, axonemal

DNAH3 DNAH12 DNAH5

8.50e-0517933536
GeneFamilyPyrin domain containing|Pyrin and HIN domain family

IFI16 AIM2

2.59e-045932995
GeneFamilyCD molecules|Toll like receptors

TLR7 TLR4

1.15e-0310932948
GeneFamilyDEAD-box helicases

DDX19B DDX19A DDX59

1.31e-0342933499
GeneFamilyTrafficking protein particle complex

TRAPPC11 TRAPPC13

2.29e-0314932772
GeneFamilyHeat shock 70kDa proteins

HSPA4 HSPA5

3.39e-0317932583
GeneFamilyAminoacyl tRNA synthetases, Class I

YARS1 IARS2

4.23e-0319932131
GeneFamilyPhospholipases|C2 domain containing phospholipases

PLCZ1 PLCG2

4.23e-0319932832
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

EHBP1 WASHC4 ZMYND8 TOPBP1 CKAP5 ARFGEF1 TRRAP BPTF TIAM1 PHF3 AFF1 STK39 PRMT3 RPGR

4.74e-0746614914M13522
CoexpressionGSE360_DC_VS_MAC_M_TUBERCULOSIS_DN

KTN1 ZMYND8 UPF3A SNUPN YARS1 PHF3 ENTPD6 MMP1 TBP

2.27e-062001499M5191
CoexpressionGSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP

TRAPPC11 REXO5 UPF3B GPATCH8 BTBD3 NARF TRAPPC13 ENTPD6

1.85e-051981498M5018
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

EHBP1 SP100 WASHC4 ZMYND8 TOPBP1 CKAP5 ARFGEF1 GPATCH8 TRRAP BPTF TIAM1 PHF3 AFF1 STK39 PRMT3 RPGR

3.11e-0585614916M4500
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000

CYLD DDX19B NCAPD3 REXO5 IFT81 HEATR1 GPATCH8 RNF17 ZRANB3 DARS2 ESF1 IARS2 CCDC138 RBM46 LTV1 HERC3 DGCR8 RPGR PLCG2

3.28e-0682014519gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlasdev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000

DDX19B RPL27A NCAPD3 HEATR1 LYAR RNF17 UBR7 ZRANB3 DARS2 ESF1 NUP205 CCDC138 RBM46 LTV1 PRMT3 HERC3 DGCR8 PLCG2

8.33e-0679514518gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000
CoexpressionAtlasdev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000

DDX19B RPL27A NCAPD3 HEATR1 GPATCH8 LYAR RNF17 ZRANB3 DARS2 ESF1 NUP205 IARS2 GSPT2 CCDC138 RBM46 LTV1 PRMT3 HERC3

1.07e-0581014518gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500_K3

TPR DDX59 IFT81 KTN1 LRRC49 CEP290 CKAP5 TLR7 TPGS2 UPF3B HEATR1 LYAR PRPF40A ZRANB3 ESF1 GSPT1 BPTF IARS2 PHF3 CCDC138 RPGR GNAO1 HSPA4

1.43e-05125714523facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlasdev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000

NCAPD3 HEATR1 RNF17 ZRANB3 ESF1 NUP205 GSPT2 RBM46 LTV1 PRMT3 HERC3

1.87e-0533314511gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_MedNas_2500_K1

TPR TRAPPC11 DDX59 CEP290 EML6 CKAP5 NCKAP5 UPF3B HEATR1 LYAR PRPF40A ESF1 IARS2 CFAP54 ATP2C2 CCDC138 HERC3 RPGR GNAO1 HSPA4

3.59e-05106014520facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3

POU6F2 KTN1 CEP290 EML6 CKAP5 LYAR PRPF40A ESF1 GSPT1 PHF3 N4BP2 HSPA4 HSPA5

7.53e-0553214513Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlasdev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000

DDX19B NCAPD3 HEATR1 LYAR RNF17 UBR7 ZRANB3 DARS2 NF2 CCDC138 RBM46 LTV1 PRMT3 HERC3 DGCR8 PLCG2

1.17e-0479914516gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500

TPR DDX59 IFT81 KTN1 LRRC49 CEP290 CKAP5 TLR7 TPGS2 UPF3B HEATR1 LYAR PRPF40A ZRANB3 ESF1 GSPT1 BPTF IARS2 PHF3 CCDC138 RPGR GNAO1 HSPA4

1.41e-04145914523facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlasdev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000

DDX19B NCAPD3 HEATR1 LYAR RNF17 UBR7 ZRANB3 DARS2 NUP205 CCDC138 RBM46 LTV1 PRMT3 HERC3 DGCR8 PLCG2

1.61e-0482214516gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4

DDX19B KTN1 CEP290 CKAP5 NCKAP5 UPF3B GSPT1 GSPT2 HSPA4

2.14e-042981459Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlasdev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000

DDX19B NCAPD3 HEATR1 LYAR RNF17 ZRANB3 DARS2 PRMT3

2.72e-042431458gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000
ToppCellPND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 IFT81 CEP290 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

2.86e-071911508bda8faf92495c8b362850c0aff4fc6fbdd9c563b
ToppCellPND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 IFT81 CEP290 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

2.86e-0719115086880fb348bb0915db9a5da4f3566ca9ff93ed258
ToppCellPND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 IFT81 CEP290 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

2.98e-071921508b5cdc2dae3154b1e4ade88f841f38584402ffe33
ToppCellNS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DNAH3 LRRC49 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

3.22e-0719415081ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH3 IFT81 CFAP54 DNAH12 PLCG2 CFAP57 DNAH5 HYDIN

3.22e-0719415084a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPIRE2 REXO5 ZRANB3 CFAP54 CCDC138 DNAH5 HYDIN

3.18e-06185150705bc89a566b0db90ae06506e067190a4739a0974
ToppCellNS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DNAH3 LRRC49 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

3.18e-0618515075e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCellEpithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4)

DNAH3 IFT81 CEP290 CFAP54 DNAH12 DNAH5 HYDIN

3.54e-0618815078f30535a32968a81a304315a49c0d90a77d36948
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

TCAF2 GPATCH8 PRX LLGL1 PHF3 HERC3 ACSL5

3.79e-061901507651a1d3ae286e40f9d9f60e438211c6148d24143
ToppCellPND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 IFT81 CEP290 CFAP54 DNAH12 DNAH5 HYDIN

4.06e-0619215072d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56
ToppCellASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

DNAH3 IFT81 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.20e-061931507a0baa8be6f590b2031fede22be588715ae458e93
ToppCellmoderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DNAH3 IFT81 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.50e-061951507e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCellcritical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DNAH3 IFT81 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.65e-06196150727b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCellPSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DNAH3 LRRC49 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.81e-0619715076865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH3 CEP290 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.81e-06197150774a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCellcritical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DNAH3 IFT81 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.97e-061981507ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPR UPF3B CFAP54 DNAH12 CFAP57 HYDIN SPATA4

4.97e-0619815071847ce8c344c8a3e50f3cbbf758a38aba69f85b0
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

TPR KTN1 CEP290 PRPF40A BPTF PHF3 DNAH5

5.14e-061991507fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCellproximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

5.14e-0619915079700f06e51ddca85e482b4f9bd4a79bfcd3cfb76
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

TPR SP100 KTN1 CEP290 ARFGEF1 BPTF PHF3

5.14e-061991507c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCellproximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

5.14e-0619915071188afad6fd5f01f9aeba225f611f38b237dd2c9
ToppCellproximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

5.14e-0619915072e8ace105c4e2405baa06d953e52888b54e2d055
ToppCellBronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

5.31e-06200150752aef65f01b06cd98056f17977efe525aee6eb6f
ToppCellLPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DNAH3 EML6 CFAP54 ATP2C2 CFAP57 DNAH5 HYDIN

5.31e-06200150796701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCellBronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

5.31e-06200150755c148238d5c80c1faa3428a917ae8075be2c145
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

5.31e-06200150731d75c26055177d656df1fbb10b764cebd61e122
ToppCellBiopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

5.31e-062001507721371698bce8890853fb6b6b01a2c20293b39e9
ToppCellParenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

5.31e-06200150785c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c
ToppCellLPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DNAH3 ARHGEF38 ATP10B CFAP54 ATP2C2 DNAH5 HYDIN

5.31e-062001507da12821e8a0657869ca0f75d351cce2d7605a505
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

5.31e-062001507e1dce91c6c531bb212002a14705e496d77ad3490
ToppCellParenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

5.31e-06200150712bc7d95c4166d12487081a76d210b7abe5991b0
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type.

RPL27A MYH8 KLHL41 NEB BPTF PHF3 SCN9A

5.31e-0620015077c261e39ac30b318511373ab7302aa53b8b81b9c
ToppCellLPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DNAH3 ARHGEF38 ATP10B CFAP54 ATP2C2 DNAH5 HYDIN

5.31e-06200150772c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCellLPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH3 ARHGEF38 CFAP54 ATP2C2 DNAH5 HYDIN

1.11e-051481506d61123f0c811287843d066b932b4a9ff09c07c5b
ToppCellLPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH3 ARHGEF38 CFAP54 ATP2C2 DNAH5 HYDIN

1.11e-051481506c8e93b87212f55774223caa385859c566fa1981f
ToppCellLPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH3 EML6 CFAP54 ATP2C2 DNAH5 HYDIN

1.39e-0515415069ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCellLPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH3 EML6 CFAP54 ATP2C2 DNAH5 HYDIN

1.39e-05154150658072ce422d09f2de602580325eaac6c4ec6c136
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

TCAF2 B3GLCT NEB TRAPPC13 PIK3R6 GNAO1

2.20e-051671506c0c944eae0514dc8e00d0c2892a0792e157695ec
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

2.35e-05169150614aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCellThalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.C1ql2_(Anterodorsal_thalamic_nucleus)|Thalamus / BrainAtlas - Mouse McCarroll V32

ARHGEF38 PRR15L MEI1 CNGA2

3.30e-055415048a8abf565ea657bf16059c51a63534ede3d7ac12
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ARHGEF38 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

3.35e-05180150692fb01b91261b3103454924cde56add337b41844
ToppCellFetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

3.45e-051811506dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCellControl-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations)

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

3.56e-051821506fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCellP07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

3.79e-051841506a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2
ToppCellP07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

3.79e-051841506ab469b9e06212462cbe2e4db8775c6778db855e6
ToppCellE18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

3.79e-051841506797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b
ToppCellE18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

3.79e-05184150677d5b60a20b277f589b18f7a131142a7ef2dac17
ToppCellCOVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations)

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

3.90e-05185150618a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCellNS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.02e-05186150676033438426d8f9c72cd6691a7baf92104c9f03d
ToppCellpdx|World / Sample and Cell Type and Tumor Cluster (all cells)

ZMYND8 GPATCH8 ZRANB3 BPTF TNRC18 CCDC138

4.02e-051861506de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCellpdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

ZMYND8 GPATCH8 ZRANB3 BPTF TNRC18 CCDC138

4.02e-0518615060b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCellCOPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.14e-051871506f0fd0792f6926f705d175f6e6fd480f12c7a3bd4
ToppCellP15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.14e-051871506a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40
ToppCellCiliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id

DNAH3 CFAP54 DNAH12 CFAP57 HYDIN SPATA4

4.14e-051871506bc1f33f332ac939c2425f510173430ca2ba0c3ee
ToppCell343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells)

HEATR1 NUP205 SP140L STK39 CLUH ATG16L2

4.27e-0518815068f6b45ad82bde65e044d17f0edbc3db90d457915
ToppCellP15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.27e-051881506e3e71c0f2e374330620cb4d27638953ffa9f5298
ToppCellPND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.40e-051891506057d7a03fdbe779122b203619a6f947f49b84d28
ToppCellPND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.40e-051891506b55de812043b670cbde810d7d42f45909b6d66ef
ToppCellPND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.40e-05189150602c6128a9ab5818e0881dcadafdad5f08b9a67cf
ToppCellPND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.40e-051891506164ea92ff6a1aa2ead1c9b8f64f99a9d65437232
ToppCellPND10-Epithelial-Epithelial_Airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.40e-051891506407d8a59969d83f014600aae1a55092283a13970
ToppCellControl-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.40e-051891506c007fccd08728db3ea99af9da91d67b9b16dabb3
ToppCellEpithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4)

DNAH3 IFT81 CFAP54 DNAH12 DNAH5 HYDIN

4.40e-0518915060bf560b595c7a8450a46bc821b742b67965bd9f9
ToppCellPND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.40e-0518915069f57a131902d23494bf389baf6e6e2d99f88b2c8
ToppCellPND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.40e-051891506a85099bd598a27ee64ee0664d051d89fa8d62fc9
ToppCellCOVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.40e-05189150627329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCellPND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.40e-0518915064e83e49d1265ffe507fdb72924c77c4d1c73f0bd
ToppCellPND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.40e-051891506e443b02502edaefa94567a9e8af5756e8e11ff30
ToppCellNasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.53e-0519015069ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCellNasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.53e-051901506833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCellCiliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.53e-0519015067031fbedc13be1a00f6333ad6d51849c3739c2e6
ToppCellBAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DNAH3 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

4.66e-0519115062a8e6d560907e71e9f6e190ca0667da804e25641
ToppCellBAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DNAH3 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

4.66e-05191150646c9d4d10c66c0fae1fa351924091b69ea2f38d4
ToppCellControl-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class

DNAH3 DNAH12 ATP2C2 CFAP57 DNAH5 HYDIN

4.66e-051911506ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCellMild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30)

DNAH3 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

4.66e-051911506995e76bbf07674d95b8ef09e078cf6410af27a09
ToppCellBAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DNAH3 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

4.66e-051911506a37f20172b85566b9039254a89680e37fd503fd5
ToppCellBAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

DNAH3 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

4.66e-0519115062d36e08c5629cf73b6dd02cd173cafb52e8a3a7d
ToppCellnucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.66e-051911506e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCellnucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.66e-0519115069d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCellControl-Epithelial|Control / Condition, Lineage and Cell class

DNAH3 DNAH12 ATP2C2 CFAP57 DNAH5 HYDIN

4.66e-0519115066228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCellPND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.66e-05191150696483adb97c81208aa513782550acd8a08b63866
ToppCellnucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.66e-0519115061c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCellBronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.80e-051921506be592e661367affced9ebe80849b466e6adb3a34
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.94e-051931506e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

CKAP5 GSPT1 BPTF N4BP2 AFF1 MIGA1

4.94e-051931506abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellNS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DNAH3 CFAP54 ATP2C2 CFAP57 DNAH5 HYDIN

4.94e-051931506ea345d34440b25f65358a53dc72831998d1c3620
ToppCellBronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

4.94e-0519315060b62a6ddd7c42efd9f39781971d1438501e1fa8d
ToppCellwk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

5.08e-051941506756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCellASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

DNAH3 IFT81 DNAH12 CFAP57 DNAH5 HYDIN

5.08e-0519415065aeb44657ab6f61b1abf98af28d3397d8e44c1aa
ToppCellCOVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

5.08e-05194150643be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

5.23e-051951506649fd2336e963f6a150d182a53ad5dd838ca80b1
ToppCellwk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

DNAH3 DNAH12 CFAP57 DNAH5 HYDIN SPATA4

5.23e-051951506cfcf554b436083179dea1d6fd6e3a800ea2430fe
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

5.23e-051951506129ad5f4253ecb1a8477cc38773e6e91ea9570b0
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

5.23e-0519515063e70ee987d66d450062d5df3d7c733ccc7344470
ToppCellmoderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

5.23e-0519515063486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCellControl_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type

DNAH3 ARHGEF38 CFAP54 ATP2C2 DNAH5 HYDIN

5.23e-05195150660067b5359174f0d1a8b5748bfc0690762e9e740
ToppCellBL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DNAH3 LRRC49 DNAH12 CFAP57 DNAH5 HYDIN

5.23e-05195150607a6bcef6af93ed87df455dee624037cb75e011a
ToppCellmLN-T_cell-gd_T|T_cell / Region, Cell class and subclass

LYAR DNAH12 METTL24 PIK3R6 CCDC138 AIM2

5.38e-0519615068f476408cd5a4ea9d25c763c66565343d7989b38
ToppCellNS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

5.38e-051961506d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCellNS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DNAH3 CFAP54 DNAH12 CFAP57 DNAH5 HYDIN

5.53e-05197150671fea4aa6ce96c7693fa94792d08770622873850
DrugEtifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A

EHBP1 TPR WASHC4 CEP290 PRPF40A ESF1 BPTF PHF3 ASPH

2.43e-0617814793998_DN
Drugconta-1(35),3,5,7(37),8,10,12,15,32(36),33-decaene-30-carboxylic acid

POLR2A CTRB2 SLCO1B3 SLCO1B1 RGS4 CTRB1

7.19e-06721476CID000489933
DrugDeltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A

EHBP1 TPR SP100 IFT81 CEP290 IFI16 PHF3 FLCN

3.37e-0519014784306_DN
Drug2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A

ATP10B IFI16 SLCO1B1 RGS4 TIAM1 ASPH GNAO1 AIM2

3.37e-0519014782700_UP
DrugBOCPheONP

CTRB2 CTRB1

4.14e-0521472CID000111308
DrugMPM-06

CTRB2 CTRB1

4.14e-0521472CID000161546
DrugNSC-374899

CTRB2 CTRB1

4.14e-0521472CID000435726
Drugmethylbenzenebutanoate

CTRB2 CTRB1

4.14e-0521472CID000281254
DrugAsp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu

CTRB2 CTRB1

4.14e-0521472CID004418081
Drug(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid

SLCO1B3 SLCO1B1

4.14e-0521472ctd:C561635
Drugc189

CTRB2 CTRB1

4.14e-0521472CID000248048
Drugdansyl-D-arginine methyl ester

CTRB2 CTRB1

4.14e-0521472CID000191369
Drugmethyl 6-phenylhexanoate

CTRB2 CTRB1

4.14e-0521472CID011820300
Drug5-aminotetrazole

CTRB2 CTRB1

4.14e-0521472CID000020467
Drug2-bromoisobutyric acid

CTRB2 CTRB1

4.14e-0521472CID000074924
Drugp-toluamidine

CTRB2 CTRB1

4.14e-0521472CID000122753
DrugN-acetyl-alpha-azaphenylalanine phenyl ester

CTRB2 CTRB1

4.14e-0521472CID000191275
Drugisobutyl sulfide

CTRB2 CTRB1

4.14e-0521472CID000011607
Drugdimethyloxalylglycine; Down 200; 1000uM; PC3; HG-U133A

CYLD REXO5 KMT2B MYT1 IFI16 PGC RGS4 ELK4

4.20e-051961478584_DN
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A

DNAH3 KMT2B PPFIBP1 IFT81 ZMYND8 TIAM1 NF2 FLCN

4.51e-0519814787003_DN
DrugSulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A

TPR CEP290 RGS4 TIAM1 MCM9 FLCN MMP1 CLUH

4.51e-0519814787366_DN
DrugDizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A

CYLD KMT2B CEP290 PRR15L UPF3A PHF3 FLCN PLCG2

4.51e-0519814782069_DN
DrugAC1L3JHX

CYLD CTRB2 GSPT1 LLGL1 NF2 CSTB CTRB1

4.65e-051461477CID000090206
DrugIsopropamide iodide [71-81-8]; Down 200; 8.4uM; PC3; HT_HG-U133A

REXO5 KMT2B CEP290 NF2 ASPH ELK4 DGCR8 RPGR

4.67e-0519914787133_DN
Drug2,4,6-tribromoanisole

NF2 FLCN TBP

5.56e-05121473CID000011839
DrugE1-P

CTRB2 ITIH1 ATP2C2 CTRB1

5.90e-05331474CID000104406
DrugA-C-A

HK1 CTRB2 PLCG2 MMP1 CTRB1

7.33e-05671475CID015955872
DrugErp tripeptide

CTRB2 MMP1 CTRB1

9.11e-05141473CID000131430
DrugN-acetylbenzotriazole

CTRB2 CTRB1

1.24e-0431472CID000087784
Drugphotophor

CTRB2 CTRB1

1.24e-0431472CID000014780
Drugdibutyl iodomethaneboronate

CTRB2 CTRB1

1.24e-0431472CID000098591
Drugzinc;dipicolinate

CTRB2 CTRB1

1.24e-0431472CID004309911
Drug2-oxobut-3-ynoate

CTRB2 CTRB1

1.24e-0431472CID000171547
DrugAFMeq

CTRB2 CTRB1

1.24e-0431472CID000194069
DrugBz-Cti-otbu

CTRB2 CTRB1

1.24e-0431472CID006452691
Drugn-(2-oxoethyl)benzamide

CTRB2 CTRB1

1.24e-0431472CID000188995
DrugAC1L49DM

CTRB2 CTRB1

1.24e-0431472CID000152933
Drugc140

CTRB2 CTRB1

1.24e-0431472CID002783250
DrugDeuteroporphyrins

HMOX2 SLCO1B1

1.24e-0431472ctd:D003905
DrugBenzamidomethaneboronic acid

CTRB2 CTRB1

1.24e-0431472CID000127677
Drugphenyl hippurate

CTRB2 CTRB1

1.24e-0431472CID000076323
DrugFK-386

CTRB2 CTRB1

1.24e-0431472CID000135044
DrugFK-375

CTRB2 CTRB1

1.24e-0431472CID000135042
Drugcarbostyril-124

CTRB2 CTRB1

1.24e-0431472CID000088277
DrugN-trifluoroacetyl-4-fluorophenylalanine

CTRB2 CTRB1

1.24e-0431472CID000328214
DrugC18 4

CTRB2 CTRB1

1.24e-0431472CID000077248
Drugtaraxastane

CTRB2 CTRB1

1.24e-0431472CID006429404
DrugPhe-phe-ome

CTRB2 CTRB1

1.24e-0431472CID000151728
Drugphenylethaneboronic acid

CTRB2 CTRB1

1.24e-0431472CID000065389
Drug3-amino-2-pyridone

CTRB2 CTRB1

1.24e-0431472CID000322353
DrugASA-BMPA

CTRB2 CTRB1

1.24e-0431472CID003035649
Drugp-nitrophenyl benzoate

CTRB2 CTRB1

1.24e-0431472CID000070396
DrugZ-Phe-OMe

CTRB2 CTRB1

1.24e-0431472CID003082435
Drug3-methylcoumarin

CTRB2 CTRB1

1.24e-0431472CID000017130
Drug2-propyl methylphosphonochloridate

CTRB2 CTRB1

1.24e-0431472CID000102124
DrugFK-316

CTRB2 CTRB1

1.24e-0431472CID000133688
DrugAC1L19T8

CTRB2 CTRB1

1.24e-0431472CID000000694
DrugMarinostatin D

CTRB2 CTRB1

1.24e-0431472CID000132206
Drug1FD7

CTRB2 CTRB1

1.24e-0431472CID000445579
DrugGlt-leu-phe-nh-meq

CTRB2 CTRB1

1.24e-0431472CID000194914
DrugAC1L4Z4F

CTRB2 CTRB1

1.24e-0431472CID000194913
DrugGlt-Phe-NH-FMeq

CTRB2 CTRB1

1.24e-0431472CID000194912
Drugdiacetyl trimer

CTRB2 CTRB1

1.24e-0431472CID000193527
DrugFK-448

CTRB2 CTRB1

1.24e-0431472CID006917869
DrugAc-Phe-OMe

CTRB2 CTRB1

1.24e-0431472CID000097805
Drugthiobenzyl N-heptafluorobutyrylanthranilate

CTRB2 CTRB1

1.24e-0431472CID000133906
DrugICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA

TPR WASHC4 KTN1 GPATCH8 PRPF40A ESF1 BPTF

1.56e-041771477985_DN
DrugCaptopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A

EHBP1 TPR WASHC4 GPATCH8 PRPF40A ESF1 BPTF

1.67e-0417914774585_DN
DrugAC1L2TMY

HK1 CTRB2 CTRB1

1.68e-04171473CID000102826
Drugirinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A

EHBP1 WASHC4 ZMYND8 PRR15L TRRAP BPTF TIAM1

1.91e-0418314777498_DN
Drugheptachlor

PLCZ1 KTN1 SCGB1D1 PI4KA FLCN PLCG2

1.94e-041291476CID000003589
Drugp203

ARFGEF1 IFI16 AIM2

2.00e-04181473CID000019228
DrugNeostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

WASHC4 CEP290 IFI16 PRPF40A BPTF PHF3 ASPH

2.25e-0418814776735_DN
DrugCloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A

EHBP1 TPR CEP290 IFI16 PHF3 ASPH HSPA4

2.33e-0418914774271_DN
DrugN-acetylphenylalanine

CTRB2 PGC CTRB1

2.37e-04191473CID000002000
DrugPz-plgpa

CTRB2 MMP1 CTRB1

2.37e-04191473CID000152296
DrugSulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A

TPR ARHGEF38 IFI16 TIAM1 PHF3 ASPH HERC3

2.40e-0419014774322_DN
DrugChloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A

EHBP1 ZMYND8 NF2 PHF3 ASPH FLCN HSPA4

2.40e-0419014772869_DN
DrugBenzoyl-dl-leucine

CTRB2 CTRB1

2.46e-0441472CID000294887
DrugAcafcek

CTRB2 CTRB1

2.46e-0441472CID000197677
DrugB-1,3-od

CTRB2 CTRB1

2.46e-0441472CID011971053
Drugdehydromerodesmosine

CTRB2 CTRB1

2.46e-0441472CID006443540
Drugalpha-amyrin palmitate

CTRB2 CTRB1

2.46e-0441472CID000185477
Drugpoly-THIQ

CTRB2 CTRB1

2.46e-0441472CID006453487
DrugN-(4-carboxycyclohexylmethyl)-maleimide

CTRB2 CTRB1

2.46e-0441472CID011548799
DrugG2505_sigma

CTRB2 CTRB1

2.46e-0441472CID000111098
DrugDihydromicrocystin Lr

SLCO1B3 SLCO1B1

2.46e-0441472CID006441227
Drugrifamycin SV

SLCO1B3 SLCO1B1

2.46e-0441472ctd:C023808
Drugp-fluorobenzenesulfonyl chloride

CTRB2 CTRB1

2.46e-0441472CID000009588
DrugBSSDA

CTRB2 CTRB1

2.46e-0441472CID003081106
Drugmicrocystin-LF

SLCO1B3 SLCO1B1

2.46e-0441472ctd:C524165
DrugAC1L2HV6

CTRB2 CTRB1

2.46e-0441472CID000047328
DrugAC1L4X1Z

CTRB2 CTRB1

2.46e-0441472CID000193815
DrugNSC-676827

CTRB2 CTRB1

2.46e-0441472CID000385555
Drug6-amino-1,2-benzopyrone

CTRB2 CTRB1

2.46e-0441472CID000046152
Drugnitrophenylethanol

CTRB2 CTRB1

2.46e-0441472CID000097851
DrugMethantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A

TPR IFT81 LRRC49 ZMYND8 UPF3A NEB FLCN

2.56e-0419214776254_DN
DrugLynestrenol [52-76-6]; Up 200; 14uM; PC3; HG-U133A

SP100 KMT2B LRRC49 CEP290 ZMYND8 HMOX2 HSPA5

2.73e-0419414771953_UP
DrugBenfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A

CYLD EHBP1 TPR CEP290 IFI16 PHF3 ASPH

2.73e-0419414774312_DN
Drug5-Br

HK1 YARS1 FLCN

2.77e-04201473CID000008057
Diseasebilirubin metabolic disorder (implicated_via_orthology)

SLCO1B3 SLCO1B1 SLCO1B7

1.20e-0651473DOID:2741 (implicated_via_orthology)
Diseasehexadecenedioate (C16:1-DC) measurement

SLCO1B3 SLCO1B1 SLCO1B7

9.95e-0691473EFO_0800562
DiseaseHYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC

SLCO1B3 SLCO1B1

2.47e-0521472C4016905
DiseaseRotor Syndrome

SLCO1B3 SLCO1B1

2.47e-0521472C0220991
Diseaselevel of chymotrypsinogen B2 in blood serum

CTRB2 CTRB1

2.47e-0521472OBA_2041192
DiseaseRotor syndrome

SLCO1B3 SLCO1B1

2.47e-0521472cv:C0220991
DiseaseHYPERBILIRUBINEMIA, ROTOR TYPE

SLCO1B3 SLCO1B1

2.47e-0521472237450
Diseaseglycochenodeoxycholate glucuronide (1) measurement

SLCO1B3 SLCO1B1 SLCO1B7

3.34e-05131473EFO_0800474
Diseasechymotrypsinogen B measurement

CTRB2 CTRB1

7.37e-0531472EFO_0801477
Diseaseserum non-albumin protein measurement

SP100 POLR2A ARHGEF38 ITIH1 NF2 SP140L AFF1 PLCG2 ATG16L2

8.70e-053611479EFO_0004568
DiseaseX-23756 measurement

SLCO1B1 SLCO1B7

2.44e-0451472EFO_0022126
DiseaseRenal carcinoma

NF2 FLCN

2.44e-0451472C1378703
Diseasebilirubin metabolic disorder (is_implicated_in)

SLCO1B3 SLCO1B1

3.65e-0461472DOID:2741 (is_implicated_in)
Diseaserenal cell carcinoma (implicated_via_orthology)

NF2 FLCN

3.65e-0461472DOID:4450 (implicated_via_orthology)
Diseasechemokine (C-C motif) ligand 27 measurement

SLCO1B3 ATP10B ITIH1 SLCO1B7

4.20e-04701474EFO_0008082
DiseaseNemaline Myopathy, Childhood Onset

KLHL41 NEB

5.09e-0471472C0546125
Diseaseplatelet reactivity measurement, thrombus formation measurement

RGS4 N4BP2

5.09e-0471472EFO_0004985, EFO_0007615
Diseaseseasonal allergic rhinitis

ENTPD6 GNAO1 DNAH5

5.40e-04321473EFO_0003956
Diseasenemaline myopathy (implicated_via_orthology)

KLHL41 NEB

6.77e-0481472DOID:3191 (implicated_via_orthology)
Diseasedeoxycholic acid glucuronide measurement

SLCO1B3 SLCO1B1

6.77e-0481472EFO_0800575
DiseaseSPINOCEREBELLAR ATAXIA 17

HSPA5 TBP

8.67e-0491472C1846707
DiseaseX-21467 measurement

SLCO1B3 SLCO1B1

8.67e-0491472EFO_0020007
Diseasepancreatitis (biomarker_via_orthology)

CTRB2 TLR4 CTRB1

9.71e-04391473DOID:4989 (biomarker_via_orthology)
Diseaseinformation processing speed, cognitive function measurement

KTN1 HSP90AA4P

1.08e-03101472EFO_0004363, EFO_0008354
DiseaseCharcot-Marie-Tooth disease

HK1 PRX YARS1

1.21e-03421473cv:C0007959
Diseasegastrointestinal stromal tumor (is_implicated_in)

SLCO1B3 NF2

1.32e-03111472DOID:9253 (is_implicated_in)
Diseasetrypsin-2 measurement

CTRB2 CTRB1

1.32e-03111472EFO_0008305
Diseasetype 1 diabetes mellitus

PRR15L CTRB2 PI4KA STK39 GNAO1 CTRB1

1.38e-032421476MONDO_0005147
DiseaseClear Cell Meningioma

NF2 CSTB

1.57e-03121472C0431121
DiseaseIntraventricular Meningioma

NF2 CSTB

1.57e-03121472C1334271
DiseaseBenign Meningioma

NF2 CSTB

1.57e-03121472C0281784
DiseaseIntraorbital Meningioma

NF2 CSTB

1.57e-03121472C1334261
DiseaseOlfactory Groove Meningioma

NF2 CSTB

1.57e-03121472C1335107
DiseaseAngioblastic Meningioma

NF2 CSTB

1.57e-03121472C1527197
DiseaseMeningiomas, Multiple

NF2 CSTB

1.57e-03121472C0205834
DiseaseXanthomatous Meningioma

NF2 CSTB

1.57e-03121472C0457190
DiseaseAngiomatous Meningioma

NF2 CSTB

1.57e-03121472C0334608
DiseasePsammomatous Meningioma

NF2 CSTB

1.57e-03121472C0334607
DiseaseFibrous Meningioma

NF2 CSTB

1.57e-03121472C0334606
DiseaseMeningothelial meningioma

NF2 CSTB

1.57e-03121472C0334605
DiseaseHemangioblastic Meningioma

NF2 CSTB

1.57e-03121472C0334609
DiseaseTransitional Meningioma

NF2 CSTB

1.57e-03121472C0334611
DiseaseHemangiopericytic Meningioma

NF2 CSTB

1.57e-03121472C0334610
DiseaseSpinal Meningioma

NF2 CSTB

1.57e-03121472C0347515
DiseaseCongenital myopathy (disorder)

NEB KY

1.57e-03121472C0270960
DiseaseIntracranial Meningioma

NF2 CSTB

1.57e-03121472C0349604
DiseasePapillary Meningioma

NF2 CSTB

1.57e-03121472C3163622
DiseaseMalignant Meningioma

NF2 CSTB

1.57e-03121472C0259785
DiseaseSphenoid Wing Meningioma

NF2 CSTB

1.57e-03121472C1565951
DiseasePosterior Fossa Meningioma

NF2 CSTB

1.57e-03121472C1565950
DiseaseParasagittal Meningioma

NF2 CSTB

1.57e-03121472C0751304
DiseaseCerebral Convexity Meningioma

NF2 CSTB

1.57e-03121472C0751303
DiseaseMicrocystic meningioma

NF2 CSTB

1.57e-03121472C1384408
DiseaseSecretory meningioma

NF2 CSTB

1.57e-03121472C1384406
DiseasePrimary Ciliary Dyskinesia

RPGR DNAH5 HYDIN

1.67e-03471473C4551720
Diseasebilirubin measurement

HK1 MYT1 ARHGEF38 SLCO1B3 SLCO1B1 SLCO1B7 AFF1 GNAO1

1.74e-034421478EFO_0004570
Diseasecannabis dependence measurement

MEI1 SCN9A PRMT3

1.78e-03481473EFO_0008457
Diseasedevelopmental and epileptic encephalopathy (implicated_via_orthology)

KCNQ4 GNAO1

1.85e-03131472DOID:0112202 (implicated_via_orthology)
DiseaseCharcot-Marie-Tooth disease type 4

HK1 PRX

1.85e-03131472cv:C4082197
Diseasecholestasis (biomarker_via_orthology)

SLCO1B3 SLCO1B1 SLCO1B7

1.89e-03491473DOID:13580 (biomarker_via_orthology)
Diseasechromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology)

PI4KA DGCR8

2.16e-03141472DOID:0060413 (implicated_via_orthology)
DiseaseHMG CoA reductase inhibitor use measurement

EHBP1 CTRB2 HERC3 GNAO1 CTRB1

2.62e-031891475EFO_0009932
Diseasecholesteatoma of middle ear (is_marker_for)

TLR4 MMP1

2.83e-03161472DOID:10964 (is_marker_for)
Diseaseresponse to methotrexate

POU6F2 SLCO1B1

2.83e-03161472GO_0031427
DiseaseX-21441 measurement

SLCO1B3 SLCO1B7

3.19e-03171472EFO_0800814
Diseaseperinatal necrotizing enterocolitis (biomarker_via_orthology)

TLR7 TLR4

3.19e-03171472DOID:8677 (biomarker_via_orthology)
Diseaseoral motor function measurement

IFI16 AIM2

3.19e-03171472EFO_0021793
Diseaseacylcarnitine measurement

SLCO1B1 SLCO1B7 METTL24 LLGL1

3.80e-031271474EFO_0005059
DiseaseMeningioma

NF2 CSTB

3.99e-03191472C0025286
Diseasecystatin C measurement

SPIRE2 IFT81 SNUPN SLCO1B1 LLGL1 ENTPD6 CSTB

4.13e-034021477EFO_0004617
Diseasememory performance

EHBP1 SPIRE2 HEATR1 NEB ITIH1 BTBD3 N4BP2

4.53e-034091477EFO_0004874
Diseasevenous thromboembolism, plasminogen activator inhibitor 1 measurement

CKAP5 PLCG2

4.86e-03211472EFO_0004286, EFO_0004792
DiseaseHbA1c measurement, response to sulfonylurea

SLCO1B1 SLCO1B7

4.86e-03211472EFO_0004541, EFO_0007922

Protein segments in the cluster

PeptideGeneStartEntry
LKIAKVFKNPKFSIL

CTRB2

101

Q6GPI1
KKKETLRDFIFKNPA

CFAP54

1416

Q96N23
KAELLDKFSKKLQPE

ATG16L2

46

Q8NAA4
FLPLCRKPVKKKDIF

B3GLCT

256

Q6Y288
KIKSTAKFPEQKLFA

ARFGEF1

1601

Q9Y6D6
AKFPEQKLFAALLIK

ARFGEF1

1606

Q9Y6D6
KVFNTLLKDKFIPKR

AIM2

191

O14862
TFIERKLSFEKKKPV

ARHGEF38

546

Q9NXL2
KEDLEKKLFKPLSQN

EXOC1L

6

A0A1B0GW35
KLLKKVALFSKLLPA

FAM47DP

96

A6NHR8
FKKVFKKSILALFES

GPR33

306

Q49SQ1
VRAFAKELFLGKIKK

ACAD9

36

Q9H845
KELFLGKIKKKEVFP

ACAD9

41

Q9H845
QLEEKENKKFPVFKA

CSTB

26

P04080
KKPELQFVSKARKGL

BTBD3

356

Q9Y2F9
LKFLKKKKPEDAFCV

AMZ2

156

Q86W34
PKLLNKFDKTIKAEL

ASPH

331

Q12797
RKFSPDLKLLKDVKI

DGCR8

106

Q8WYQ5
KFVTKSSKKSIFVLP

BPTF

1836

Q12830
VFFRTSPKHKLKIIK

ATP2C2

646

O75185
KTLNAIFQGKLEKKF

ATP10B

1001

O94823
LLKLLQKFGKVKQFD

RBM18

41

Q96H35
FNKFKPGAVERVKKL

RBM46

256

Q8TBY0
KILKKHKPDFISLFK

NUP205

41

Q92621
FTLPKVSAKTKFKLT

LLGL1

836

Q15334
SEFAQKLLKKFSLLK

LACRT

121

Q9GZZ8
KKPFIEKKKAVSFHL

LTV1

6

Q96GA3
RIPAVKEKISKFFGK

HSPA4

346

P34932
KVLFKFTKVDSRPKE

FLCN

516

Q8NFG4
FLPKELAAQTIKKSF

ITIH1

211

P19827
ATAKVKPKKLAFSNF

PPFIBP1

896

Q86W92
EFPLEKKKKFLLFLT

HERC3

971

Q15034
KKKKFLLFLTGSDRI

HERC3

976

Q15034
GKFALKIFVKKRQEP

KY

531

Q8NBH2
KLKVFDLLKDEAPQK

ASMTL

306

O95671
DLKKKNQELGKFKFV

CFAP57

961

Q96MR6
KFLVAKRKFKETLRP

KCNQ4

541

P56696
KKLFEILNDKKLFKP

DDX59

431

Q5T1V6
KAKDLLALFNSFKPK

ESF1

361

Q9H501
CKEKLVPFLKKVGFS

GSPT2

366

Q8IYD1
KKAPVKLESIASVFK

GPATCH8

306

Q9UKJ3
FFKIKPLLKSAETEK

MYH8

836

P13535
LIKSDKFKDIPFNKN

KIAA1586

581

Q9HCI6
EIFKTLKFFQTKLKK

DNAH12

726

Q6ZR08
QSAAKAPYLAKFKVK

PI4KA

1796

P42356
PDLQKKIKVLKDAFA

KLHL41

246

O60662
LKIKFPNSLHLKFKE

LRRC49

461

Q8IUZ0
EAKEVLKKLFPKVSV

KTN1

1071

Q86UP2
LPFVIKFVSRAKKVK

KMT2B

301

Q9UMN6
PLINFKVSSAKFLKD

PLCG2

171

P16885
DFLKGNIKKELFKLA

HMOX2

56

P30519
RKIKDKKLPVGFTFS

HK1

141

P19367
ECKEKLVPFLKKVGF

GSPT1

236

P15170
FTIKPLDKKIDVFKF

NF2

271

P35240
VLKALSFPKKKAALL

MEI1

1041

Q5TIA1
IINKKDKDKFPVLVL

PCDHA10

181

Q9Y5I2
AKQAFKELLKEKRVP

PRPF40A

396

O75400
VEFAPFQKAAKKKTK

UPF3B

131

Q9BZI7
QKKPLAKKVLGDFFE

EBLN1

266

P0CF75
KVFPKEKLKQCKSEF

CKAP5

1741

Q14008
VGKIQKFKVKFSPLD

HYDIN

3901

Q4G0P3
FPKELENKKKELHFL

IFT81

281

Q8WYA0
KLSKIKSNKKLFELF

CCDC138

606

Q96M89
KIKIDKFKQYIPILS

DNAH3

931

Q8TD57
KLFKLIKTENPAEKL

ELK4

161

P28324
KQTVFLLEKPFSVKA

PRMT3

481

O60678
IKKLKKELENFDPSF

CEP290

2406

O15078
IKKPIKTKFRLPVFN

FMNL3

561

Q8IVF7
SKLKFIDPKKIKVFV

DDX19B

226

Q9UMR2
AKTPLKKFLLKLAVS

ACSL5

366

Q9ULC5
LKFKPLSKKVVSAAL

EHBP1

136

Q8NDI1
QEKFFKRKPKVLGVV

MS4A4E

36

Q96PG1
FNIDLKEKFTPKKII

IFI16

616

Q16666
VIFNKKISKNPTFKL

LYAR

356

Q9NX58
KKFATLPRKESAVKQ

EXOC1

441

Q9NV70
FSLKKFIYALKAPKS

HEATR1

791

Q9H583
LVKLFKFPCLKRGAK

EML6

541

Q6ZMW3
APFELLETRKKKNKI

HSP90AA4P

151

Q58FG1
KDFKLFKKIFPSLEL

CYLD

761

Q9NQC7
KLKFIDPKKIKVFVL

DDX19A

226

Q9NUU7
DIKFLPFKVVEKKTK

HSPA5

111

P11021
KEIPFSVKKTKSIFN

ZMYND8

326

Q9ULU4
LKIAKVFKNPKFSIL

CTRB1

101

P17538
KTIIKKLFFFRSGKQ

RILPL2

196

Q969X0
KQLPKEAKRFSNIDK

DNAH5

1646

Q8TE73
FKEKKKVRATLAENP

PRR15L

76

Q9BU68
KKFKEPITSALQKLE

PACRGL

211

Q8N7B6
KLPKQPVIVKAKFFS

RPL27A

116

P46776
PVAKLAKFTFKQKSK

MCM9

916

Q9NXL9
LSALIVKARKNPKKF

MIGA1

416

Q8NAN2
KDLSKPQLFLKKDIF

METTL24

336

Q5JXM2
KKIFLFKRVPSINQK

RPGR

951

Q92834
ACKKLPFEIKNFVKK

DARS2

151

Q6PI48
LKPKKKVFEKLQADF

YARS1

481

P54577
KKFSEKVKKNLVPFF

TCAF2

871

A6NFQ2
LLQKVKKVFKASPFL

ENTPD6

196

O75354
VQRKKPSVAFKKPIF

NCKAP5

991

O14513
KFDPKTKRILTLQKA

MMP1

446

P03956
KLSPKAKKIYNEFIS

RGS4

106

P49798
SPEALKFKILVKNKK

PLCZ1

286

Q86YW0
FEKLDITPKSAQKIK

POU6F2

561

P78424
AVVEFAPFQKIAKKK

UPF3A

146

Q9H1J1
ILFLNKKDLFGEKIK

GNAO1

266

P09471
LKVKIQDSKFPKDGF

PIK3R6

561

Q5UE93
LREFILKAFSKKPKI

SCN9A

1006

Q15858
VFKSAPILKRALKVK

STRIP1

691

Q5VSL9
TNAKFSIKKEAPFVL

TECTB

161

Q96PL2
AAKELLKKVKFIPGS

IARS2

491

Q9NSE4
KKFKLSLVGLAKLAF

SLCO1B7

351

G3V0H7
KTKLNPFKFVGLKNF

SNUPN

221

O95149
KLEISNAIKKTFPFL

SP140L

61

Q9H930
IIKKFKLNTVGIAKF

SLCO1B1

396

Q9Y6L6
LAGKPVFKFQLAKFK

SCGB1D1

36

O95968
TFEKTDLKVPAKAKL

AFF1

321

P51825
KNFLRLLPKFSLKEK

NCAPD3

221

P42695
DKGTKKKFELFVLDP

CNGA2

121

Q16280
PTFKKNFAVLQKKRV

CLUH

291

O75153
FKELLKQPLEKFELK

NLRP9

26

Q7RTR0
KIKDEFLNAPEKAIK

RNF17

776

Q9BXT8
KFLARKKFKLPKELI

SPATA4

116

Q8NEY3
LTKQDKLKSPFKFSD

TNRC18

1636

O15417
VTDKKIAILGFAFKK

UGDH

326

O60701
PGKTRKLLFKFVAKT

TRAPPC11

661

Q7Z392
KVPKVLVKAKTDTAF

TIAM1

1151

Q13009
AAVVKVPLKKFKSIR

PGC

16

P20142
KLPKSVQNKLEKFLA

TPR

16

P12270
VQKLGFPAKFLDFKI

TBP

241

P20226
FLQNKELFSSLKKGK

SPIRE2

556

Q8WWL2
FKLKFLAKVILGKDI

REXO5

341

Q96IC2
KLKVSKFAISLPKAR

PRX

956

Q9BXM0
LATLKPSNKAFEKKF

POLR2A

906

P24928
IIKKFKLSLVGIAKF

SLCO1B3

396

Q9NPD5
KVEISNAIKKTFPFL

SP100

61

P23497
FNLKDPKNNILFKKV

PHF3

986

Q92576
IILIFLEKPFQKSKF

TLR7

986

Q9NYK1
LEKPFQKSKFLQLRK

TLR7

991

Q9NYK1
PFKHDVFLLEKEKKL

ZNF234

51

Q14588
SFVNKLDPSKVFKSK

TPGS2

241

Q68CL5
IQEEKLKPFEKFLLK

WASHC4

236

Q2M389
FKNLECKLLPDKAKV

UBR7

106

Q8N806
SILPAIFQKKLKQKF

TMEM41B

276

Q5BJD5
KIVDDPKALKTLTFK

STK39

506

Q9UEW8
RKFFKFQVLKPLDVK

TRAPPC13

161

A5PLN9
KFGQFPTLKLKSLKR

TLR4

341

O00206
FLSKDKLFKPSFDVK

TOPBP1

826

Q92547
KILEAKTKQLPKFFL

TRRAP

3446

Q9Y4A5
KTKQLPKFFLIEEKC

TRRAP

3451

Q9Y4A5
NAFFLKVTALTKKPD

SIGLEC11

146

Q96RL6
KLLPFQKDGIIFALK

ZRANB3

36

Q5FWF4
AFSTNPELAKKIKIF

LIPK

181

Q5VXJ0
ILKLKKGKFPFHFVE

NARF

356

Q9UHQ1
KNILFVIAKPDVFKS

NACAD

1441

O15069
ATKLKEKQLFKIFPA

N4BP2

1521

Q86UW6
LAFKKGDLLVLTKKQ

MYO7B

1521

Q6PIF6
LTNFKLKFLSKDIKK

MYT1

781

Q01538
KAKKFDIKVDAIPLL

NEB

816

P20929